Literature DB >> 10825005

Mapping the amplification of EIF3S3 in breast and prostate cancer.

N N Nupponen1, J Isola, T Visakorpi.   

Abstract

Gain of chromosome arm 8q is a frequent genetic alteration in breast and prostate cancer. Two amplified subregions, 8q21 and 8q23-24, have been identified with comparative genomic hybridization (CGH). We have recently demonstrated that the EIF3S3 (eIF3-p40) gene, located at 8q23, is often amplified and overexpressed in both breast and prostate cancer. Here, we used fluorescence in situ hybridization (FISH) to map the amplified region around EIF3S3 in primary breast cancers and cell lines. The size of the common highly amplified region was about 2.5 Mb between the markers D8S1668 and WI-7959. Next, we analyzed the expression of all expressed sequence tags (ESTs) located within and near this region by RNA slot blot hybridization. In addition to EIF3S3, three anonymous ESTs and EXT1 were found to be highly expressed in cancer cell lines with the amplification at 8q23-q24. However, the anonymous ESTs were located outside the minimal highly amplified region and EXT1 was overexpressed only in one of the cancer cell lines with 8q amplification. Since EIF3S3 was the only consistently overexpressed gene located in the minimal highly amplified region, it is the strongest candidate target gene for 8q23-q24 amplification.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10825005

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  11 in total

1.  An oncogenic role for the phosphorylated h-subunit of human translation initiation factor eIF3.

Authors:  Lili Zhang; Zeljka Smit-McBride; Xiaoyu Pan; Jeanette Rheinhardt; John W B Hershey
Journal:  J Biol Chem       Date:  2008-06-10       Impact factor: 5.157

2.  Mapping and gene expression profile of the minimally overrepresented 8q24 region in prostate cancer.

Authors:  Norihiko Tsuchiya; Yasushi Kondo; Atsushi Takahashi; Hemant Pawar; Junqi Qian; Kazunari Sato; Michael M Lieber; Robert B Jenkins
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

3.  Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer.

Authors:  O Saramäki; N Willi; O Bratt; T C Gasser; P Koivisto; N N Nupponen; L Bubendorf; T Visakorpi
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

4.  Prognostic value of TERF1 expression in prostate cancer.

Authors:  Gabriel Arantes Dos Santos; Nayara Izabel Viana; Ruan Pimenta; Vanessa Ribeiro Guimarães; Juliana Alves de Camargo; Poliana Romão; Sabrina T Reis; Katia Ramos Moreira Leite; Miguel Srougi
Journal:  J Egypt Natl Canc Inst       Date:  2021-09-06

5.  Knockdown of eIF3D inhibits breast cancer cell proliferation and invasion through suppressing the Wnt/β-catenin signaling pathway.

Authors:  Yan Fan; Yufei Guo
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  MYC and EIF3H Coamplification significantly improve response and survival of non-small cell lung cancer patients (NSCLC) treated with gefitinib.

Authors:  Federico Cappuzzo; Marileila Varella-Garcia; Elisa Rossi; Sujatha Gajapathy; Marialuisa Valente; Harry Drabkin; Robert Gemmill
Journal:  J Thorac Oncol       Date:  2009-04       Impact factor: 15.609

7.  Integration of DNA copy number alterations and transcriptional expression analysis in human gastric cancer.

Authors:  Biao Fan; Somkid Dachrut; Ho Coral; Siu Tsan Yuen; Kent Man Chu; Simon Law; Lianhai Zhang; Jiafu Ji; Suet Yi Leung; Xin Chen
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

8.  Quantitative Analysis of Seven New Prostate Cancer Biomarkers and the Potential Future of the 'Biomarker Laboratory'.

Authors:  Kevin Cao; Callum Arthurs; Ali Atta-Ul; Michael Millar; Mariana Beltran; Jochen Neuhaus; Lars-Christian Horn; Rui Henrique; Aamir Ahmed; Christopher Thrasivoulou
Journal:  Diagnostics (Basel)       Date:  2018-07-27

9.  Mucin 1 (MUC1) is a novel partner for MAL2 in breast carcinoma cells.

Authors:  Susan Fanayan; Mona Shehata; Annelies P Agterof; Michael A McGuckin; Miguel A Alonso; Jennifer A Byrne
Journal:  BMC Cell Biol       Date:  2009-01-28       Impact factor: 4.241

10.  Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer.

Authors:  K J Savinainen; M J Linja; O R Saramäki; T L J Tammela; G T G Chang; A O Brinkmann; T Visakorpi
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.